Mark Wirth
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
- Antibiotics Pharmacokinetics and Efficacy 2
- Genetics 3
- Glioma Diagnosis and Treatment 2
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
- Co-authors
- Kevin B. Alton (7 shared papers)Ian W. Knemeyer (1 shared paper)Jaime A. Yáñez (1 shared paper)Stephen W.J. Wang (1 shared paper)Paul Statkevich (4 shared papers)Vijay K. Batra (2 shared papers)Eric Keith Rowinsky (1 shared paper)Pascale Reidenberg (1 shared paper)
- Journals
- Xenobiotica (3 papers)Advanced Drug Delivery Reviews (1 paper)The Journal of Clinical Pharmacology (1 paper)European Journal of Pharmacology (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- United States
In The Last Decade
Mark Wirth
9 papers receiving 680 citations
Peers
Comparison fields: 5 of 95
- Pharmaceutical Science 121
- Genetics 111
- Pharmacology 60
- Drug Discovery 1
- Biomaterials 71
Countries citing papers authored by Mark Wirth
This map shows the geographic impact of Mark Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wirth more than expected).
Fields of papers citing papers by Mark Wirth
This network shows the impact of papers produced by Mark Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wirth. The network helps show where Mark Wirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 225 | |
| 2 | Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. | 1999 | 207 |
| 3 | 2000 | 83 | |
| 4 | 2004 | 53 | |
| 5 | 2011 | 48 | |
| 6 | 2007 | 31 | |
| 7 | 1999 | 26 | |
| 8 | 2007 | 25 | |
| 9 | 2015 | 18 |
About Mark Wirth
Mark Wirth is a scholar working on Pharmacology, Genetics, Pharmacology, Physiology and Clinical Biochemistry, having authored 9 papers that have together received 716 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Glioma Diagnosis and Treatment (2 papers), Glycogen Storage Diseases and Myoclonus (1 paper), Inhalation and Respiratory Drug Delivery (1 paper), Respiratory and Cough-Related Research (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Pharmaceutical Science (121 citations), Genetics (111 citations), Pharmacology (60 citations), Drug Discovery (1 citation) and Biomaterials (71 citations). Mark Wirth has collaborated with scholars based in United States. Frequent co-authors include Kevin B. Alton, Ian W. Knemeyer, Jaime A. Yáñez, Stephen W.J. Wang, Paul Statkevich, Vijay K. Batra, Eric Keith Rowinsky, Pascale Reidenberg, David L. Cutler and Margaret Han Dugan. Their work appears in journals such as Xenobiotica, Advanced Drug Delivery Reviews, The Journal of Clinical Pharmacology, European Journal of Pharmacology and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.